FZD4

Across TCGA pan-cancer cohorts, FZD4 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated FZD4 data layer compared with 26 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher FZD4 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated FZD4 expression acts as an unfavorable survival marker.

COAD, STAD, and LUSC are the cancer types where FZD4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	II,III,IV	0.164	0.758	<.001	14	view →
STAD	OS	Median	II,III,IV	0.075	0.660	<.001	12	view →
LUSC	DFS	Median	All	0.064	0.791	<.001	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
LUAD	OS	Median	All	0.276	0.697	.040	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

FZD4–COAD (DFS)

Open the COAD breakdown →